David W. Yandell

8.6k citations

67 papers · 7.0k indexed · 1 hit paper · h-index 38

Molecular Biology top 2%
Oncology top 0.5%
Ophthalmology top 0.5%
Cancer Research top 1%
Genetics top 2%

Co-authors: Thaddeus P. Dryja John B. Little Kenshi Hayashi Terri L. McGee Junya Toguchida Glenn S. Cowley Elias Reichel Eliot L. Berson
Topics: Cancer-related Molecular Pathways (34 papers)Ocular Oncology and Treatments (20 papers)Cancer Genomics and Diagnostics (12 papers)
Cited by: Ophthalmology Oncology Cancer Research
Journals: Nature Science New England Journal of Medicine
Partner nations: United States Germany Japan

In The Last Decade

David W. Yandell

67 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A point mutation of the rhodopsin gene in one form of retinitis pigmentosa

1990 806 citations Thaddeus P. Dryja, Terri L. McGee et al. profile →

Peers

Countries citing papers authored by David W. Yandell

Since Specialization

Citations

This map shows the geographic impact of David W. Yandell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Yandell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Yandell more than expected).

Fields of papers citing papers by David W. Yandell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Yandell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Yandell. The network helps show where David W. Yandell may publish in the future.

Co-authorship network of co-authors of David W. Yandell

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Yandell. A scholar is included among the top collaborators of David W. Yandell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Yandell. David W. Yandell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Higher Stromal Expression of Transforming Growth Factor-beta Type II Receptors is Associated with Poorer Prognosis Breast Tumors 2003 ·Breast Cancer Research and Treatment ·John Barlow,David W. Yandell,Donald L. Weaver,Theresa Casey,Karen Plaut	26
2	Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma 2003 ·Clinical Endocrinology ·Trisha M. Shattuck,Teresa S. Kim,Jessica L. Costa,David W. Yandell,Yasuo Imanishi,Nallasivam Palanisamy,Randall D. Gaz,Dolores Shoback,Orlo H. Clark,John M. Monchik,Margaret E. Wierman,Anthony N. Hollenberg,Katsuyoshi Tojo,R. S. K. Chaganti,Andrew Arnold	47
3	Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction 2000 ·British Journal of Cancer ·Jolanta Kupryjańczyk,Agnieszka Dansonka‐Mieszkowska,T Szymańska,(unknown),Alina Rembiszewska,Marek Rusin,Ryszard Konopiński,Ewa Kraszewska,Agnieszka Timorek,David W. Yandell,J Stelmachów	11
4	Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma 1996 ·Cancer Letters ·Mitsuo Kato,Takashi Shimizu,Kanji Ishizaki,Akihiro Kaneko,David W. Yandell,Junya Toguchida,Masao S. Sasaki	45
5	Adenocarcinoma of the Cardia in a Young Man: Detection of Somatic p53 Mutation by Immunohistochemistry and Automated Direct Sequencing 1995 ·Pathology - Research and Practice ·Christopher Poremba,David W. Yandell,W. Mellin,K. W. Schmid,B. Reers,W. Böcker,Barbara Dockhorn‐Dworniczak	2
6	Detection of heterozygous mutation in the retinoblastoma gene in a human pituitary adenoma using PCR-SSCP analysis and direct sequencing 1995 ·Endocrine Pathology ·Hidetoshi Ikeda,Roberta L. Beauchamp,Takashi Yoshimoto,David W. Yandell	8
7	Potential location of a bladder tumor suppressor gene on chromosome 9q at 9q13 to 9q22.1 1995 ·Urologic Oncology Seminars and Original Investigations ·Chi‐Wei Lin,(unknown),David J. Kwiatkowski,William U. Shipley,W. Scott McDougal,David W. Yandell	1
8	The retinoblastoma gene is involved in malignant progression of astrocytomas 1994 ·Annals of Neurology ·John W. Henson,(unknown),(unknown),Andreas von Deimling,(unknown),Hong‐Ji Xu,William F. Benedict,David W. Yandell,David N. Louis	179
9	p53Expression in Ovarian Borderline Tumors and Stage I Carcinomas 1994 ·American Journal of Clinical Pathology ·Jolanta Kupryjańczyk,(unknown),David W. Yandell,R E Scully,Ann D. Thor	56
10	Hypervariable Regionen (HVR) als genetische Marker in der Tumordiagnostik 1994 ·Der Pathologe ·(unknown),David W. Yandell,Ira J. Spiro,(unknown),W. B�cker,Barbara Dockhorn‐Dworniczak	1
11	Rapid detection of loss of heterozygosity of chromosome 17p by polymerase chain reaction-based variable number of tandem repeat analysis and detection of single-strand conformation polymorphism of intragenic p53 polymorphisms 1994 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Barbara Dockhorn‐Dworniczak,Christopher Poremba,(unknown),(unknown),(unknown),S. Blasius,W. B�cker,W. Mellin,Albert Roessner,David W. Yandell	10
12	Hormone production andc-myc protein labeling in plurihormonal pituitary adenomas 1994 ·Endocrine Pathology ·Hidetoshi Ikeda,Takashi Yoshimoto,David W. Yandell	5
13	Complete Genomic Sequence of the Human Retinoblastoma Susceptibility Gene 1993 ·Genomics ·Junya Toguchida,Terri L. McGee,Jennifer C. Paterson,(unknown),Stephanie C. Tucker,David W. Yandell,Thaddeus P. Dryja	119
14	How sensitive is PCR-SSCP? 1993 ·Human Mutation ·Kenshi Hayashi,David W. Yandell	389
15	Prevalence and Spectrum of Germline Mutations of the p53 Gene among Patients with Sarcoma 1992 ·New England Journal of Medicine ·Junya Toguchida,Toshikazu Yamaguchi,(unknown),(unknown),Guillermo E. Herrera,Kanji Ishizaki,Takao Yamamuro,Paul A. Meyers,John B. Little,Masao S. Sasaki,Ralph R. Weichselbaum,David W. Yandell	227
16	Molecular mechanisms of spontaneous and induced loss of heterozygosity in human cells in vitro 1992 ·Somatic Cell and Molecular Genetics ·Chuan‐Yuan Li,David W. Yandell,John B. Little	62
17	Detection of theXbal RFLP within the retinoblastoma locus by PCR 1990 ·Nucleic Acids Research ·Terri L. McGee,Glenn S. Cowley,David W. Yandell,Thaddeus P. Dryja	34
18	Molecular genetic analysis of recessive mutations at a heterozygous autosomal locus in human cells 1990 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·David W. Yandell,Thaddeus P. Dryja,John B. Little	77
19	Oncogenic Point Mutations in the Human Retinoblastoma Gene: Their Application to Genetic Counseling 1989 ·New England Journal of Medicine ·David W. Yandell,T Campbell,(unknown),Robert A. Petersen,David S. Walton,John B. Little,Allyn McConkie‐Rosell,Edward G. Buckley,Thaddeus P. Dryja	235
20	Structure and partial genomic sequence of the human retinoblastoma susceptibility gene 1989 ·Gene ·Terri L. McGee,David W. Yandell,Thaddeus P. Dryja	121

About David W. Yandell

David W. Yandell is a scholar working on Ophthalmology, Oncology and Cancer Research, having authored 67 papers that have together received 7.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (34 papers), Ocular Oncology and Treatments (20 papers) and Cancer Genomics and Diagnostics (12 papers). The work is most often cited by research in Ophthalmology (1.2k citations), Oncology (3.1k citations) and Cancer Research (1.2k citations). David W. Yandell has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Thaddeus P. Dryja, John B. Little, Kenshi Hayashi, Terri L. McGee, Junya Toguchida, Glenn S. Cowley, Elias Reichel, Eliot L. Berson, Michael A. Sandberg and Lauri B. Hahn. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact